In general, patients with severe COVID-19 show a high concentration of Gal3, which can serve as a potential biomarker for predicting COVID-19 severity, prognosis, and treatment response, as suggested by multiple studies [89,90,91,92]. The gene discussed is LGALS3; the disease is COVID-19.